Does postmenopausal estrogen administration increase the risk of breast cancer? Contributions of animal, biochemical, and clinical investigative studies to a resolution of the controversy

Proceedings of the Society for Experimental Biology and Medicine
B Zumoff

Abstract

Despite nearly six decades of epidemiological studies, meta-analyses, and reviews, there is still considerable controversy in the literature about the question, does postmenopausal estrogen administration increase the risk of breast cancer? In an effort to resolve the controversy, a number of animal, biochemical, and clinical investigative studies in this field have been reviewed. The following summary formulation is proposed: 1. Administration of estrogen is inherently capable of promoting the growth of breast cancer, and therefore of increasing the incidence of clinical breast cancer. 2. Human response to estrogen is like that of the low-cancer-incidence strains of mice studied by Lacassagne, in that large doses and prolonged administration are required to induce clinical breast cancer. 3. The blood levels of estradiol produced by the usual doses of postmenopausal estrogen are relatively low, equivalent to those of the follicular phase of the menstrual cycle. These levels may be near the threshold for producing breast-cancer-promoting effects; therefore, the tumor response will vary greatly in different populations, depending on genetic susceptibility factors: a. The prevalence of a family history of premenopausal breast canc...Continue Reading

Citations

Jun 26, 2007·Breast Cancer Research and Treatment·Christina JustenhovenHiltrud Brauch
May 9, 2009·Breast Cancer Research and Treatment·UNKNOWN MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
Aug 13, 2009·Breast Cancer Research and Treatment·UNKNOWN MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
Sep 12, 2001·The Surgical Clinics of North America·K Lin, C D Runowicz
Dec 11, 1999·Pharmacology, Biochemistry, and Behavior·J M Vongher, C A Frye
Oct 26, 1999·Experimental Gerontology·M M Miller, K B Franklin
Mar 15, 2002·The Journal of Nutritional Biochemistry·Bahram H. Arjmandi, Brenda J. Smith
Nov 19, 2003·The Journal of Steroid Biochemistry and Molecular Biology·W YueE L Cavalieri
May 24, 2003·Best Practice & Research. Clinical Endocrinology & Metabolism·P Kenemans, A Bosman
Dec 7, 2007·Chemical Research in Toxicology·Judy L Bolton, Gregory R J Thatcher
Feb 5, 2013·Journal of the National Cancer Institute·Xiang ShuXifeng Wu
Oct 12, 2000·Journal of Epidemiology and Community Health·R A Wiseman
Jul 1, 2011·Journal of Biomedicine & Biotechnology·Raquel Alves dos SantosCatarina Satie Takahashi
Aug 29, 1998·Environmental Health Perspectives·D L DavisA J Sasco
Dec 3, 2013·Pharmacology & Therapeutics·Todd P Knutson, Carol A Lange
Apr 9, 2014·Journal of Translational Medicine·Liang ShiXiujun Cai
Apr 18, 2008·Chemical Research in Toxicology·Shuang DingSuse Broyde
Sep 26, 2015·International Journal of Molecular Sciences·Daniel WysokinskiElzbieta Pawlowska
Jan 28, 2010·International Journal of Cancer. Journal International Du Cancer·Wei YueRichard Santen
Aug 21, 2008·Biological Chemistry·Margarida CepaNatércia A Teixeira
Oct 20, 2018·Journal of Mammary Gland Biology and Neoplasia·Hugo VillanuevaDean P Edwards
Jun 16, 1999·Endocrine Reviews·F Cosman, R Lindsay
Mar 16, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Alastair E CribbTarek M Saleh
Mar 22, 2000·Chemical Research in Toxicology·J L BoltonT J Monks

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.